Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17497106.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inflammation plays an important role in vulnerability of atherosclerotic plaques to rupture and hence acute coronary events. The monocyte-macrophage infiltration in plaques leads to upregulation of cytokines and metalloproteinase enzymes. Matrix metalloproteinases result in matrix dissolution and consequently expansive remodeling of the vessel. They also contribute to attenuation of fibrous cap and hence susceptibility to rupture. Assessment of metalloproteinase expression and activity should provide information about plaque instability.
Medical subject headings
- Atherosclerosis
- Drug Delivery Systems
- Matrix Metalloproteinases
- Positron-Emission Tomography
- Radiopharmaceuticals